İmdat Yüce

494 citations
40 papers · 335 indexed · h-index 11

İmdat Yüce

37 papers receiving 322 citations

Peers

İmdat Yüce
Comparison fields: 5 of 57
  • Otorhinolaryngology 108
  • Oncology 101
  • Surgery 138
  • Ophthalmology 26
  • Oral Surgery 17
Replace Emiro Caicedo‐Granados with:
Emiro Caicedo‐Granados United States
Neeraja Konuthula United States
Brendan Conn United Kingdom
Paolo Balercia Italy
Corso Bocciolini Italy
Anna Bozzola Italy
Janjira Petsuksiri Thailand
Rebecca C. Hoesli United States
E. Towpik Poland
Edward G. Bernacki United States
İmdat Yüce relative to Emiro Caicedo‐Granados United States Emiro Caicedo‐Granados's profile →
Citations per field
00.5×8.7×
Emiro Caicedo‐Granados · 1×
Citations per year

Countries citing papers authored by İmdat Yüce

Since Specialization
Citations

This map shows the geographic impact of İmdat Yüce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İmdat Yüce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İmdat Yüce more than expected).

Fields of papers citing papers by İmdat Yüce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İmdat Yüce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İmdat Yüce. The network helps show where İmdat Yüce may publish in the future.

Co-authorship network

The 25 scholars most cited alongside İmdat Yüce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with İmdat Yüce Line = papers co-authored together İmdat Yüce links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20230
3 20211
4 20194
5 20194
6 20181
7 20171
8 20164
9 201612
10 20157
11 201420
12 20147
13 201028
14
Giant pleomorphic adenoma of the parotid gland.
20092
15 20095
16 200932
17 200923
18 20089
19 200815
20 200435

About İmdat Yüce

İmdat Yüce is a scholar working on Otorhinolaryngology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 40 papers that have together received 335 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (12 papers), Cancer Diagnosis and Treatment (8 papers), Ear and Head Tumors (5 papers), Tracheal and airway disorders (5 papers), Head and Neck Anomalies (4 papers), Voice and Speech Disorders (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (108 citations), Oncology (101 citations), Surgery (138 citations), Ophthalmology (26 citations) and Oral Surgery (17 citations). İmdat Yüce has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Sedat Çağlı, Ercìhan Güney, Ali̇ Bayram, Alperen Vural, Özlem Canöz, Yaşar Ünlü, İbrahim Ketenci, Mehmet Şentürk, Emel Köseoğlu and Orhan G. Yigitbasi. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, American Journal of Otolaryngology, Thyroid, Clinical Otolaryngology and Otolaryngology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026